Abstract
The design of cytocompatible polymer materials without any cytotoxicity is an essential and important part in the preparation of nanodevices for the delivery of bioactive molecules. The phospholipid polymer 2-methacryloyloxyethyl phosphorylcholine (MPC) is a strong candidate to provide such nanodevices because of its excellent cytocompatibility. Water-soluble MPC polymers bearing hydrophobic monomer units can form a stable polymer aggregate structure in biological milieus because of their amphiphilic nature. The obtained polymer aggregate can solubilize poorly soluble molecules, including bioactive molecules. In addition, MPC polymers containing active ester units to immobilize bioactive molecules are useful to investigate the bioactivity of immobilized molecules because non-specific interactions with biomolecules are reduced. The concept of a “cell-shuttle” that can penetrate the cell membrane without showing any cytotoxicity will be described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- MPC:
-
2-Methacryloyloxyethyl phosphorylcholine
- BMA:
-
n-Butyl methacrylate
- MEONP:
-
p-Nitrophenyloxycarbonyl poly(oxyethylene) methacrylate
- PLA:
-
Poly(L-lactic acid)
- R8:
-
Octaarginine peptide
- PTX:
-
Paclitaxel
References
Goda T, Goto Y, Ishihara K (2010) Cell-penetrating macromolecules: direct penetration of amphipathic phospholipid polymers across plasma membrane of living cells. Biomaterials 31(8):2380–2387
Goto Y, Matsuno R, Konno T et al (2008a) Polymer nanoparticles covered with phosphorylcholine groups and immobilized with antibody for high-affinity separation of proteins. Biomacromolecules 9(3):828–833
Goto Y, Matsuno R, Konno T et al (2008b) Artificial cell membrane-covered nanoparticles embedding quantum dots as stable and highly sensitive fluorescence bioimaging probe. Biomacromolecules 9(11):3252–3257
Ishihara K (2000) New polymeric biomaterials-phospholipid polymers with a biocompatible surface. Front Med Biol Eng 10:83–95
Ishihara K, Ueda T, Nakabayashi N (1990) Preparation of phospholipid polymers and their properties as polymer hydrogel membrane. Polym J 22:355–360
Ishihara K, Nomura H, Mihara T et al (1998) Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res 39:323–330
Ishihara K, Iwasaki Y, Nakabayashi N (1999) Polymeric lipid nanosphere consisting of water-soluble poly (2-methacryloyloxyethyl phosphoryl choline-co-n-butyl methacrylate). Polym J 31:1231–1236
Ito T, Watanabe J, Takai M et al (2006) Dual mode bioreactions on polymer nanoparticles covered with phosphorylcholine group. Colloids Surf B Biointerfaces 50(1):55–60
Iwasaki Y, Nakabayashi N, Ishihara K (2001) Preservation of platelet function on 2-methacryloyloxyethyl phosphorylcholine graft polymer compared to various water-soluble graft polymers. J Biomed Mater Res 57:72–78
Kamei T, Kitayama J, Yamaguchi H et al (2011) Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co-n-butyl methacrylate) in peritoneal metastatic nodules. Cancer Sci 102(1):200–205
Kojima R, Kasuya M, Ishihara K et al (2011) Physicochemical delivery of amphiphilic copolymers to specific organelles. Polym J 43:718–722
Konno T, Watanabe J, Ishihara K (2003) Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomed Mater Res 65A:209–214
Konno T, Watanabe J, Ishihara K (2004) Conjugation of enzymes on polymer nanoparticles covered with phosphorylcholine groups. Biomacromolecules 5:342–347
Konno T, Ito T, Takai M et al (2006) Enzymatic photochemical sensing of hydrogen peroxide by polymer nanoparticles covered with artificial cell membrane. J Biomater Sci Polym Edn 17(12):1347–1357
Miyata R, Ueda M, Jinno H et al (2009) Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel. Int J Cancer 124(10):2460–2467
Moro T, Takatori Y, Ishihara K et al (2004) Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis. Nat Mater 3:829–836
Shimada T, Ueda M, Jinno H et al (2009) Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles. Anticancer Res 29(4):1009–1014
Singer SJ, Nicholson GL (1972) The fluid mosaic model of the structure of cell membranes. Science 175:720–731
Snyder TA, Tsukui H, Kihara S, Akimoto T, Litwak KN, Kameneva MV, Yamazaki K, Wagner WR (2007) Preclinical biocompatibility assessment of the EVAHEART ventricular assist device: coating comparison and platelet activation. J Biomed Mater Res A 81:85–92
Soma D, Kitayama J, Konno T et al (2009) Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co-n-butyl methacrylate) for peritoneal dissemination of gastric cancer. Cancer Sci 100(10):1979–1985
Watanabe J, Ishihara K (2006) Sequential enzymatic reactions and stability of biomolecules immobilized onto phospholipid polymer nanoparticles. Biomacromolecules 7:171–175
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Konno, T. (2014). Cytocompatible Phospholipid Polymers for Non-invasive Nanodevices. In: Prokop, A., Iwasaki, Y., Harada, A. (eds) Intracellular Delivery II. Fundamental Biomedical Technologies, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-8896-0_13
Download citation
DOI: https://doi.org/10.1007/978-94-017-8896-0_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-8895-3
Online ISBN: 978-94-017-8896-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)